Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder

Primary Psychiatry

Volumn 14, Issue 8, 2007, Pages 19-20

  Ginsberg, David L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; CLONAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; BEHAVIOR THERAPY; CASE REPORT; COGNITIVE THERAPY; COMORBIDITY; DRUG DOSE TITRATION; HUMAN; MAJOR DEPRESSION; MALE; NEUROSURGERY; OBSESSIVE COMPULSIVE DISORDER; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34548095479     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Fineberg NA, Gale TM, Sivakumaran T. A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol. 2006;20:97-103.
2. Friedman S, Abdallah TA, Oumaya M, Rouillon F, Guelfi JD. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2007;68(6):972-973.
3. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
4. Ability [package insert]. San Francisco, CA: Bristol-Myers Squibb; 2005.
5. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry. 2005;66(1):49-51.